| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $18.0M | +0.0% |
| R&D Expense | $25.7M | -38.2% |
| SG&A Expense | $14.9M | -2.4% |
| Operating Income | -$40.6M | -4.5% |
| Pre-tax Income | -$39.3M | -2.2% |
| Net Income | -$39.3M | -2.2% |
| EPS (Basic) | -$0.98 | +3.9% |
| EPS (Diluted) | -$0.98 | +3.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.6M | +341.2% |
| Short-term Investments | $7.8M | -90.6% |
| Current Assets | $45.3M | -50.9% |
| Total Assets | $45.3M | -51.3% |
| Current Liabilities | $6.1M | -63.1% |
| Total Liabilities | $6.1M | -63.1% |
| Stockholders' Equity | $39.1M | -48.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.8M | -69.1% |
| Capital Expenditures | $7K | -98.4% |
| Investing Cash Flow | $74.1M | +226.2% |
| Financing Cash Flow | $0 | -100.0% |
| Free Cash Flow | -$45.8M | -66.5% |